Eventide Healthcare & Life Sciences Fd Cl N

Frequently Asked Questions About ETNHX

What does ETNHX invest in?

Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.

What is the expense ratio of ETNHX?

Eventide Healthcare & Life Sciences Fd Cl N (ETNHX) charges an expense ratio of 1.51%. This is the annual fee deducted from fund assets to cover management and operations.

How big is ETNHX?

Eventide Healthcare & Life Sciences Fd Cl N (ETNHX) manages $1.80B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is ETNHX actively managed or an index fund?

ETNHX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was ETNHX launched?

Eventide Healthcare & Life Sciences Fd Cl N (ETNHX) launched in December 2012 and is managed by the fund issuer.

How has ETNHX performed?

ETNHX's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.